FENNEC PHARMACEUTICALS INC. — Director's Dealing 2022

Oct 20, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2022-10-20

Reporting Person: RALLIS CHRIS A (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-20	Common Shares	M	4762	$1.05	Acquired	32419	Direct
2022-10-20	Common Shares	F	2068	$8.26	Disposed	30351	Direct

Footnotes

F1: Represents options granted on November 11, 2012, with a $1.05 USD strike price and an expiration of November 11, 2022.

F2: Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 4,762 shares from an November 11, 2012 grant.